Dow Jones futures rose slightly on Sunday evening, along with the S&P 500 and Nasdaq futures. The stock market rebound fell last week, but major indices reduced losses at Friday’s close, and the Nasdaq was once again facing a major hurdle.
X
The Dow Jones UnitedHealth (UNH) component soared into a buying area on Friday with strong gains, pushing other health insurers beyond points of purchase, including Centene (CNC) and Humana (HUM). Option Care Health (OPCH) and Shockwave Medical (SWAV) also jumped into the shopping areas.
It’s a big week for China’s electric vehicle giants Tesla (TSLA) and BYD (BYDDF). Tesla’s gains are due Wednesday night, with investors looking to see how the automaker withstood Covid closures and other headwinds last quarter. BYD, which announced booming preliminary profits last week, will begin selling the Seal sedan, a rival to the Model 3. On Monday, both Tesla and BYD shares fell significantly last week and need time to repair.
Chip stocks are not close to being actionable. But they are showing some signs of strength amid a long and painful downward trend. This is a positive sign for a sustained market rebound.
UNH shares are on the IBD ranking table. UnitedHealth and CNC shares are at IBD 50. HUM shares are at IBD Big Cap 20. Option Care Health was the existence of IBD on Friday. The video embedded in the article discussed market action and analyzed the actions of UnitedHealth, Option Health Care and SWAV.
Dow Jones futures today
Dow Jones futures were 0.1% above fair value. S&P 500 futures were up 0.12% and Nasdaq 100 futures were up 0.4%.
Remember that overnight action on Dow futures and elsewhere does not necessarily translate into actual trading at the next normal stock market session.
Join IBD experts as they discuss actionable stock recovery actions on IBD Live
Stock market meeting
The stock market rebound fell for most of the week, but recovered most of its losses in the end.
The Dow Jones Industrial Average fell 0.2% on the stock market last week. The S&P 500 index sank 0.9%. The Nasdaq compound fell 1.7%. Russell 2000 small capitalization fell 1.4%
The 10-year Treasury yield fell 17 basis points to 2.93%. The two-year Treasury yield rose 5 basis points to 3.12%. The Treasury yield curve reversed from two to 10 years is a warning of recession, but it is a little less reversed than at midweek. The 1-year yield, which moved above the two-year yield for much of the week, closed at 3.1%.
U.S. crude futures fell 6.9% to $ 95.78 a barrel last week, even after rising sharply from Thursday’s lows.
ETFs
Among the best ETFs, the Innovator IBD 50 ETF (FFTY) sank 0.9% last week, while the Innovator IBD Breakout Opportunities ETF (BOUT) fell 0.6. The iShares expanded technology software (IGV) sector ETF fell 4.4%, with a ServiceNow (ARA) warning affecting the sector. The VanEck Vectors Semiconductor ETF (SMH) came out almost 3%.
SPDR S&P Metals & Mining ETF (XME) was down 0.1% last week. The Global X US Infrastructure Development ETF (PAVE) gained 1 cent. US Global Jets ETFs (JETS) were up 1.4%. SPDR S&P Homebuilders ETF (XHB) rose 0.5%. The Energy Select SPDR ETF (XLE) fell 3% and the Financial Select SPDR ETF (XLF) fell 0.9%. The SPDR Fund for the Select Health Sector (XLV) fell 0.4%, recovering at the end of the week. UNH shares are one of the main shares of XLV.
Reflecting more speculative stocks, ARK Innovation ETF (ARKK) fell 5.9% last week and ARK Genomics ETF (ARKG) fell 2.9%, with highly valued software and growth struggling. Tesla shares are a major stake in Ark Invest ETFs. Cathie Wood’s Ark also has some BYD shares.
Five best Chinese stocks to watch now
Actions in shopping areas
UnitedHealth’s gains easily outperformed second-quarter views early Friday. UNH shares jumped 5.4% on Friday to 529.75, bouncing above a 518.80 buy point from what is a cup-shaped base with a handle or a double-bottomed base with a handle. For much of the week, UnitedHealth shares fell, testing its 50-day line on Thursday before recovering for a slight gain. The relative strength line, the blue line of the provided graphs, is at an all-time high, reflecting the strong superior performance of UNH shares.
UnitedHealth’s gains also lifted rivals. Centene shares rose 4.55% to 89.66, above a double-bottom buy point of 87.44, according to MarketSmith analysis. Shares of Humana rose 3.2% to 487.54, recovering an entry of 475.54. Both Centene and HUM shares reported gains later this month.
Shares of Option Care rose 7.7% on Friday to 31.58 in bulk. This eliminated a base buying point of 31.18 times. But the best entry was 30.41, just above a handling not at all. The RS line of OPCH shares has reached new highs. Option Care Health admissions expire on July 27th.
Shares of Shockwave rebounded 5.2% to 209.90 on Friday, eliminating a not-quite-good handling that offered an early entry of 208.28. This SWAV stock entry also coincides with a long trend line since the November peak. The RS line is already at a new high, even with the Shockwave highs. However, Friday’s low volume was not ideal.
Tesla Earnings Loom
Tesla earnings are due Wednesday night. The second quarter was affected by a long closure of the Shanghai plant due to the blockade of the city by Covid, followed by a long recovery until full production. The Berlin and Austin factories have also had a slow rise. Still, analysts expect Tesla’s earnings to rise 26% from the previous year, though that will end a five-quarter series of three-digit growth. Sales growth should cool to an annual increase of 42%. Both the EPA and revenue are expected to fall significantly from the first quarter.
Investors will look for guidance for the rest of the year, as well as any hints of future products. CEO Elon Musk said Friday that prices for Tesla vehicles, which have skyrocketed over the past year, could fall if raw material costs fall.
Shares of Tesla fell 4.3% to 720.20 last week, falling just below the 50-day line, but staying above the 21-day line. It could be said that TSLA shares have forged a fund base, but there is not much upward trend from the May lows.
BYD seal of approval?
The BYD label will officially go on sale on July 18th. The Model 3 rival, with a similar range and dimensions but for $ 10,000 cheaper, will likely begin deliveries a few days later.
Pre-orders for the Seal, which began in late May, are very high.
While Tesla and BYD may claim the crown of electric vehicles, this is the first clear face-to-face case for automakers. It will not be the last. BYD is expected to launch the Sea Lion, a rival to the Model Y crossover, later this year.
Shares of BYD fell 8.6% to 37.74 last week. Shares fell from rumors that Warren Buffett’s Berkshire Hathaway (BRKB) was selling part or all of its large BYD stake for a long time. There has been no confirmation of this so far.
BYD shares regained weekly lows of 32.91 after the battery and electric vehicle giant reported a booming preliminary gain for the first half that was well above sight. Analysts expect even stronger profits and margins in the second half, as production continues to rise and BYD shifts to higher-priced vehicles and margin.
Still, the BYD stock chart needs time to repair and forge a new foundation.
Tesla Vs. BYD: Which EV giant is better to buy?
Analysis of market concentration
Ultimately, the major indices ended with losses between small and modest, but it was not a quiet week.
The stock market recovery started badly, with the fall of the Nasdaq on Monday from its 10-week line, where it has met resistance several times. Major indices continued to slide, but managed to recover Wednesday and Thursday lows, despite inflation reports that increased the odds of even greater rises in Fed rates. On Friday, stocks rebounded sharply, with the Nasdaq, Dow Jones and S&P 500 regaining their 21-day lines.
Despite some major changes, the Nasdaq actually had an internal week and continues with a recent streak of higher lows, although other indices briefly lowered the previous week’s lows.
The Nasdaq is once again close to its 50-day, 10-week averages. Will the technology-heavy compound spin the tail again near those levels? A decisive move above 10 weeks, which would probably also mean eliminating the late June / early July peaks, would be a positive sign. But there would still be several other key resistance levels along the way.
For now, the market recovery continues under pressure, limited and highly volatile. It’s a tricky time to invest.
The macroeconomic climate remains difficult. Wednesday’s CPI report was unpleasant, with a terrifying headline figure and details suggesting recent inflationary pressures, even as petrol prices fall. Friday’s economic data was more optimistic. June retail sales and the New York Fed’s Empire State manufacturing index in July were stronger than expected. Crucially, import prices, price indicators in the Empire’s factory survey, and inflation expectations bode well for future inflation. Markets expect another Fed rate hike of 75 basis points on July 27 with the chances of a full point move below 30% from approximately 80% on Wednesday.
The medical sector remains the key area of market strength. While some names faltered during the week, many regained key levels on Thursday, while UNH gains boosted rivals and others on Friday.
Discount retailers look healthy.
More generally, there are some bursts of hope and encouraging green shoots. Weak gains and guidance helped drive stocks lower earlier in the week, while good results, including those from UnitedHealth, Taiwan Semiconductor (TSM) and Citigroup (C), helped drive gains later.
Do you want to make quick profits and avoid big losses? Try SwingTrader
Chips Ahoy?
Chip stocks rebounded for the second week in a row, helped by Taiwian Semi’s strong gains and guidance. This is a positive sign, because it is difficult to have a broad market rebound without chips playing a major role. The semiconductor industry has a large market capitalization, especially for the Nasdaq, so only weight is important. In addition, chips are found in almost everything from computers …